3 research outputs found
Evaluating higher education teaching performance using combined analytic hierarchy process and data envelopment analysis
Evaluating higher education teaching performance is complex as it involves consideration of both objective and subjective criteria. The student evaluation of teaching (SET) is used to improve higher education quality. However, the traditional approaches to considering students’ responses to SET questionnaires for improving teaching quality have several shortcomings. This study proposes an integrated approach to higher education teaching evaluation that combines the analytical hierarchy process (AHP) and data envelopment analysis (DEA). The AHP allows consideration of the varying importance of each criterion of teaching performance, while DEA enables the comparison of tutors on teaching as perceived by students with a view to identifying the scope for improvement by each tutor. The proposed teaching evaluation method is illustrated using data from a higher education institution in Greece
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
Background Epidermal growth factor receptor inhibitors (EGFRI) produce various dermatologic side effects in the majority of patients, and guidelines are crucial for the prevention and treatment of these untoward events. The purpose of this panel was to develop evidence-based recommendations for EGFRI-associated dermatologic toxicities. Methods A multinational, interdisciplinary panel of experts in supportive care in cancer reviewed pertinent studies using established criteria in order to develop first-generation recommendations for EGFRI-associated dermatologic toxicities. Results Prophylactic and reactive recommendations for papulopustular (acneiform) rash, hair changes, radiation dermatitis, pruritus, mucositis, xerosis/fissures, and paronychia are presented, as well as general dermatologic recommendations when possible. Conclusion Prevention and management of EGFRI-related dermatologic toxicities is critical to maintain patients’ health-related quality of life and dose intensity of antineoplastic regimens. More rigorous investigation of these toxicities is warranted to improve preventive and treatment strategies